Sales decline 49.65% to Rs 10.85 crore
Net Loss of Parabolic Drugs reported to Rs 77.31 crore in the quarter ended June 2016 as against net loss of Rs 76.84 crore during the previous quarter ended June 2015. Sales declined 49.65% to Rs 10.85 crore in the quarter ended June 2016 as against Rs 21.55 crore during the previous quarter ended June 2015. ParticularsQuarter EndedJun. 2016Jun. 2015% Var.Sales10.8521.55 -50 OPM %-295.30-158.05 -PBDT-63.93-59.76 -7 PBT-77.31-76.84 -1 NP-77.31-76.84 -1Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
